Alerts will be sent to your verified email
Verify Email
THYROCARE
|
Thyrocare Tech.
|
Vijaya Diagnostic
|
Vimta Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.41 % | 19.71 % | 12.51 % |
|
5yr Avg Net Profit Margin
|
18.13 % | 21.45 % | 11.37 % |
|
Price to Book
|
12.5 | 13.45 | 7.71 |
|
P/E
|
64.21 | 71.33 | 41.35 |
|
5yr Avg Cash Conversion Cycle
|
-55.2 Days | -131.27 Days | 122.88 Days |
|
5yr Average Interest Coverage Ratio
|
65.11 | 8.11 | 21.55 |
|
5yr Avg ROCE
|
26.01 % | 21.83 % | 16.46 % |
|
5yr Avg Operating Profit Margin
|
30.0 % | 41.52 % | 25.53 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.11 |
|
5yr CAGR Net Profit
|
-4.08 % | 11.11 % | 43.08 % |
|
5yr Average Return on Assets
|
14.94 % | 12.95 % | 9.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.06 % | 52.63 % | 36.67 % |
|
Share Pledged by Promoters
|
100.0 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.12 % | -2.41 % | -0.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.94 % | 10.79 % | -1.48 % |
|
Thyrocare Tech.
|
Vijaya Diagnostic
|
Vimta Labs
|
|---|